i3 Consult in close partnership with Manolo Beelke & Partners (http://manolobeelke.com) is proud to announce the formal establishment of its AllianCe of Excellence (ACE) Consortium. This group of handpicked CROs allows us to take advantage of geographical or indication-related specialization, without the disadvantages of big full-service CROs.
So far the participating members are the following entities listed below in alphabetical order however more CRO entities are due to join us shortly. Watch this space and visit http://www.i3consult.com/i3-partnership/ for more details and further updates.
CLINWIN Research Services is our gateway to clinical development services in Africa with its headquarters based in Nairobi, Kenya. CLINWIN provides outsourced clinical development and strategic consulting services to global pharmaceutical and biotechnology companies, academic medical centres, site management organizations, investigator sites, non-profit research organizations as well as product development partnerships. CLINWIN also delivers on a wide range of capabilities to accelerate development programs of life saving health technologies and interventions in the developing world.
The Fullcro professional network has been servicing clinical trials for more than twenty years. Their know-how allows them to propose solutions for “Interventional study” right through to the “observational study” phase, calibrated with the right risk-to-benefit ratio and with particular attention to cost containment, while ensuring compliance and quality.Fullcro have a proprietary eCRF validated & certificated 21 CFR Part 11 FDA 100% compliant. Fullcro run clinical study also for: biosimilars, supplements, nutraceuticals, cosmetics and medical devices.
Phoenix Clinical Research is a regional full-service CRO established in Lebanon. It covers the entire Middle East and North Africa region with a unique service profile that combines the flexibility and responsiveness of a growing and dynamic CRO entity. With a solid expertise of more than 13 years of international and Middle Eastern clinical research experience, it is one of the few to have the local Middle Eastern in addition to Western expertise. Phoenix CR aims to work with biopharmaceutical and healthcare experts in every field, such as but not limited to, medical writing, biostatistics, health economics, regulatory services, clinical trials monitoring and management.
Resbiomed is one of the first privately owned Companies for Clinical Research in Bulgaria. Established in 2000, Resbiomed has grown steadily and strategically for more than 17 years building our expertise and client relationships to become one of the niche leading and most highly trusted CROs in the Balkans. Today Resbiomed is strategically in addition to the Balkans is located in Asia Pacific region, to align with and respond to its client’s evolving needs in biologics.
Verum has been the first Western-Standard CRO specializing in CEE countries, with its operations starting as early as 1992. As the first registered CRO in Central Eastern Europe, it enjoys close relationships with key opinion leaders, senior clinical investigators and regulatory authorities in the CEE region. Verum has a track record of completing more than 160 trials with as many as 37.000 patients. Its biggest trial to date for one particular country, was 1,896 patients in 77 active sites!
With this ACE Consortium already there is significant service coverage both geographically and by clinical specialism. However we are at the stage of confirming further signatories from several other geographical and success critical therapeutic areas to ensure that the ACE Consortium is on track to becoming truly an international global brand of a boutique full service CRO covering pre-clinical to post-marketing service delivery. Thus both, small and large studies, will be performed with the highest possible level of flexibility, within the shortest time frame, at the most competitive cost, but without compromising on data quality.
Please feel free to fill our i3 Consult Project Request Form by clicking here.